Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
BioAge Labs, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.64 | -$0.64 | -$0.64 |
BioAge Labs, Inc. Earnings Date And Information
BioAge Labs, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-6.7 earnings per share for the quarter, missing analysts' consensus estimates of $-0.72 by $5.98. The company had revenue of 0 for the quarter and had revenue of 0 for the year. BioAge Labs, Inc. has generated $-9 earnings per share over the last year ($-8.55 diluted earnings per share) and currently has a price-to-earnings ratio of -0.22. BioAge Labs, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
BioAge Labs, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.72 | -$6.70 | -5.98 | $0 | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$1.80 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$1.74 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$2.81 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$1.96 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$2.30 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$1.48 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioAge Labs, Inc. Earnings: FAQ's
The conference call for BioAge Labs, Inc.'s latest earnings report can be listened to online.
The conference call transcript for BioAge Labs, Inc.'s latest earnings report can be read online.
BioAge Labs, Inc. (:BIOA) has a recorded net income of $-63,854,000.BioAge Labs, Inc. has generated $-8.55 earnings per share over the last four quarters.
BioAge Labs, Inc. (:BIOA) has a price-to-earnings ratio of -0.22 and price/earnings-to-growth ratio is 0.